pSivida Corp. Reports Fiscal 2017 First Quarter Results and Provides Update on Corporate Objectives & Milestone Timeline
November 7, 2016 New Leadership Focused on Increasing Commercial Potential of Proven Durasert™ Sustained Release Platform Company Continues Focus on MAA and NDA Filings for Uveitis Product in 2017 Conference ...